DKK 265.4
(2.47%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 16.54 Billion DKK | 12.78% |
2022 | 14.66 Billion DKK | 6.65% |
2021 | 13.75 Billion DKK | 34.94% |
2020 | 10.19 Billion DKK | -10.0% |
2019 | 11.32 Billion DKK | 5.02% |
2018 | 10.78 Billion DKK | 7.56% |
2017 | 10.02 Billion DKK | 11.03% |
2016 | 9.03 Billion DKK | 14.38% |
2015 | 7.89 Billion DKK | 15.88% |
2014 | 6.81 Billion DKK | 2.11% |
2013 | 6.67 Billion DKK | 8.9% |
2012 | 6.12 Billion DKK | 6.06% |
2011 | 5.77 Billion DKK | 16.51% |
2010 | 4.95 Billion DKK | 22.89% |
2009 | 4.03 Billion DKK | 8.31% |
2008 | 3.72 Billion DKK | -16.47% |
2007 | 4.45 Billion DKK | 7.56% |
2006 | 4.14 Billion DKK | 13.77% |
2005 | 3.64 Billion DKK | 9.4% |
2004 | 3.33 Billion DKK | 32.13% |
2003 | 2.52 Billion DKK | 0.64% |
2002 | 2.5 Billion DKK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.25 Billion DKK | -49.53% |
2024 Q2 | 4.25 Billion DKK | 0.0% |
2023 FY | 16.54 Billion DKK | 12.78% |
2023 Q4 | 8.43 Billion DKK | 101.43% |
2023 Q3 | 4.18 Billion DKK | -49.08% |
2023 Q2 | 8.21 Billion DKK | 101.13% |
2023 Q1 | 4.08 Billion DKK | -45.43% |
2022 Q4 | 7.48 Billion DKK | 97.42% |
2022 Q3 | 3.79 Billion DKK | -45.65% |
2022 Q1 | 3.54 Billion DKK | -49.4% |
2022 Q2 | 6.97 Billion DKK | 97.06% |
2022 FY | 14.66 Billion DKK | 6.65% |
2021 Q1 | 3.26 Billion DKK | -46.34% |
2021 Q3 | 3.46 Billion DKK | -48.37% |
2021 Q4 | 6.99 Billion DKK | 101.76% |
2021 Q2 | 6.71 Billion DKK | 106.1% |
2021 FY | 13.75 Billion DKK | 34.94% |
2020 Q1 | 2.12 Billion DKK | -62.17% |
2020 Q2 | 4.27 Billion DKK | 101.03% |
2020 Q3 | 2.96 Billion DKK | -30.58% |
2020 Q4 | 6.07 Billion DKK | 104.61% |
2020 FY | 10.19 Billion DKK | -10.0% |
2019 Q1 | 2.85 Billion DKK | 1.55% |
2019 FY | 11.32 Billion DKK | 5.02% |
2019 Q2 | 5.7 Billion DKK | 100.0% |
2019 Q3 | 2.81 Billion DKK | -50.68% |
2019 Q4 | 5.62 Billion DKK | 100.0% |
2018 Q3 | 2.8 Billion DKK | 7.73% |
2018 Q1 | 2.6 Billion DKK | 2.02% |
2018 Q4 | 2.8 Billion DKK | 0.0% |
2018 FY | 10.78 Billion DKK | 7.56% |
2018 Q2 | 2.6 Billion DKK | 0.0% |
2017 FY | 10.02 Billion DKK | 11.03% |
2017 Q4 | 2.55 Billion DKK | 0.0% |
2017 Q3 | 2.55 Billion DKK | 3.07% |
2017 Q2 | 2.47 Billion DKK | 0.0% |
2017 Q1 | 2.47 Billion DKK | 4.71% |
2016 Q1 | 2.18 Billion DKK | 5.23% |
2016 Q2 | 2.18 Billion DKK | 0.0% |
2016 Q3 | 2.36 Billion DKK | 8.33% |
2016 FY | 9.03 Billion DKK | 14.38% |
2016 Q4 | 2.36 Billion DKK | 0.0% |
2015 FY | 7.89 Billion DKK | 15.88% |
2015 Q4 | 2.07 Billion DKK | 0.0% |
2015 Q3 | 2.07 Billion DKK | 10.93% |
2015 Q2 | 1.87 Billion DKK | 0.0% |
2015 Q1 | 1.87 Billion DKK | 7.16% |
2014 Q4 | 1.74 Billion DKK | 0.0% |
2014 Q3 | 1.74 Billion DKK | 5.21% |
2014 Q1 | 1.66 Billion DKK | 0.27% |
2014 FY | 6.81 Billion DKK | 2.11% |
2014 Q2 | 1.66 Billion DKK | 0.0% |
2013 FY | 6.67 Billion DKK | 8.9% |
2013 Q4 | 1.65 Billion DKK | 0.0% |
2013 Q3 | 1.65 Billion DKK | 3.24% |
2013 Q2 | 1.6 Billion DKK | 0.0% |
2013 Q1 | 1.6 Billion DKK | 4.39% |
2012 Q1 | 1.53 Billion DKK | 6.06% |
2012 Q2 | 1.53 Billion DKK | 0.0% |
2012 FY | 6.12 Billion DKK | 6.06% |
2012 Q3 | 1.53 Billion DKK | 0.28% |
2012 Q4 | 1.53 Billion DKK | 0.0% |
2011 Q1 | 1.44 Billion DKK | 16.51% |
2011 Q4 | 1.44 Billion DKK | 0.0% |
2011 FY | 5.77 Billion DKK | 16.51% |
2011 Q3 | 1.44 Billion DKK | 0.0% |
2011 Q2 | 1.44 Billion DKK | 0.0% |
2010 Q4 | 1.23 Billion DKK | 0.0% |
2010 Q2 | 1.23 Billion DKK | 0.0% |
2010 Q3 | 1.23 Billion DKK | 0.0% |
2010 Q1 | 1.23 Billion DKK | 22.89% |
2010 FY | 4.95 Billion DKK | 22.89% |
2009 FY | 4.03 Billion DKK | 8.31% |
2009 Q1 | 1 Billion DKK | 8.31% |
2009 Q2 | 1 Billion DKK | 0.0% |
2009 Q3 | 1 Billion DKK | 0.0% |
2009 Q4 | 1 Billion DKK | 0.0% |
2008 FY | 3.72 Billion DKK | -16.47% |
2008 Q4 | 931.35 Million DKK | 0.0% |
2008 Q3 | 931.35 Million DKK | 0.0% |
2008 Q2 | 931.35 Million DKK | 0.0% |
2008 Q1 | 931.35 Million DKK | -16.47% |
2007 Q4 | 1.11 Billion DKK | 0.0% |
2007 Q3 | 1.11 Billion DKK | 0.0% |
2007 FY | 4.45 Billion DKK | 7.56% |
2007 Q2 | 1.11 Billion DKK | 0.0% |
2007 Q1 | 1.11 Billion DKK | 7.56% |
2006 Q2 | 1.03 Billion DKK | 0.0% |
2006 Q3 | 1.03 Billion DKK | 0.0% |
2006 Q4 | 1.03 Billion DKK | 0.0% |
2006 Q1 | 1.03 Billion DKK | 13.77% |
2006 FY | 4.14 Billion DKK | 13.77% |
2005 Q1 | 911.13 Million DKK | 9.4% |
2005 Q4 | 911.13 Million DKK | 0.0% |
2005 FY | 3.64 Billion DKK | 9.4% |
2005 Q3 | 911.13 Million DKK | 0.0% |
2005 Q2 | 911.13 Million DKK | 0.0% |
2004 Q1 | 832.84 Million DKK | 32.13% |
2004 Q2 | 832.84 Million DKK | 0.0% |
2004 FY | 3.33 Billion DKK | 32.13% |
2004 Q3 | 832.84 Million DKK | 0.0% |
2004 Q4 | 832.84 Million DKK | 0.0% |
2003 Q1 | 630.31 Million DKK | 0.64% |
2003 FY | 2.52 Billion DKK | 0.64% |
2003 Q4 | 630.31 Million DKK | 0.0% |
2003 Q3 | 630.31 Million DKK | 0.0% |
2003 Q2 | 630.31 Million DKK | 0.0% |
2002 Q4 | 626.32 Million DKK | 0.0% |
2002 FY | 2.5 Billion DKK | 0.0% |
2002 Q1 | 626.32 Million DKK | 0.0% |
2002 Q2 | 626.32 Million DKK | 0.0% |
2002 Q3 | 626.32 Million DKK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Ambu A/S | 2.96 Billion DKK | -458.73% |
ChemoMetec A/S | 367.59 Million DKK | -4400.605% |
GN Store Nord A/S | 8.94 Billion DKK | -84.952% |
Scandinavian Medical Solutions A/S | 34.72 Million DKK | -47537.117% |
ViroGates A/S | 5.8 Million DKK | -284895.693% |